Loading...

US Demand And China Approval Will Boost Vision Care Access

Published
16 May 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
0%
7D
0%

Author's Valuation

AU$0.3762.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value